Apotex Aripiprazole Tablets 2mg Recall: Drug May Not Meet Specifications
Apotex recalls 2mg Aripiprazole tablets due to potential failure to meet specifications. This prescription drug may not be safe throughout its shelf life. Consumers should check their product details and contact Apotex for guidance.
Lower-risk recall
Superpotent Drug: Product may not meet specifications throughout shelf life.
Contact the company
What happened, in plain English
Apotex is recalling 2mg Aripiprazole tablets because they may not meet safety specifications over time. This means the medication could be less effective or unsafe as it ages, especially for people taking it regularly. Read more at govinfonow.com/recall/42119-apotex-aripiprazole-tablets-2mg-recall-drug-may-not-meet-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/42119-apotex-aripiprazole-tablets-2mg-recall-drug-may-not-meet-specifications · Updated October 8, 2026 · FDA enforcement record: FDA #D-0471-2017
Cite this page
“Apotex Aripiprazole Tablets 2mg Recall: Drug May Not Meet Specifications.” GovInfoNow, updated October 8, 2026. https://govinfonow.com/recall/42119-apotex-aripiprazole-tablets-2mg-recall-drug-may-not-meet-specifications. Based on FDA recall #D-0471-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0471-2017%22&limit=1).
Why it’s dangerous
The tablets may not meet the required specifications for potency or safety as they age. This could lead to inconsistent medication effects or potential health risks for patients relying on the drug.
Who’s affected
Prescription patients using Aripiprazole tablets from Apotex. Those with specific medical conditions requiring precise dosing are at higher risk.
How to tell if you have this one
Check for the product name 'Aripiprazole Tablets, 2 mg, 30-count bottle' with the lot number MJ7746 and expiration date 04/17. The product is manufactured by Apotex Inc. in Toronto, Canada.
- Brand
Apotex- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number MJ7746 and expiration date 04/17 on the packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 5.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0471-2017 (December 19, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0471-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 8, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.